Trial intelligence / Profile preview

Omiganan for facial seborrheic dermatitis

NCT03688971Phase 2Unknown

Sponsor
Maruho Co., Ltd.
Start
Oct 2018
Primary completion
Dec 2019
Countries
1
01

Overview

A Phase 2 trial of CLS001 topical gel vehicle in seborrheic dermatitis (SD), sponsored by Maruho Co., Ltd.. Status: unknown.

02

Drugs

CLS001 topical gel vehicle
03

Conditions

seborrheic dermatitis (SD)

Beyond the preview

Go deeper on NCT03688971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03688971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call